Wakelee HA - Search Results

1

Improved survival and disease control following pembrolizumab-induced immune-related adverse events in high PD-L1 expressing non-small cell lung cancer with brain metastases.

Zhang M, Rodrigues AJ, Pollom EL, Gibbs IC, Soltys SG, Hancock SL, Neal JW, Padda SK, Ramchandran KJ, Wakelee HA, Chang SD, Lim M, Hayden Gephart M, Li G. Zhang M, et al. Among authors: wakelee ha. J Neurooncol. 2021 Mar;152(1):125-134. doi: 10.1007/s11060-020-03686-3. Epub 2021 Jan 7. J Neurooncol. 2021. PMID: 33415659 Free PMC article.

2

Novel approaches for the treatment of small cell lung cancer.

Wakelee H, Kelly K. Wakelee H, et al. Hematol Oncol Clin North Am. 2004 Apr;18(2):499-518. doi: 10.1016/j.hoc.2004.01.001. Hematol Oncol Clin North Am. 2004. PMID: 15094184 Review. No abstract available.

3

Docetaxel in advanced non-small cell lung cancer.

Wakelee H, Ramalingam S, Belani CP. Wakelee H, et al. Expert Rev Anticancer Ther. 2005 Feb;5(1):13-24. doi: 10.1586/14737140.5.1.13. Expert Rev Anticancer Ther. 2005. PMID: 15757434 Review.

4

Second- and third-line treatments in non-small cell lung cancer.

Kumar A, Wakelee H. Kumar A, et al. Curr Treat Options Oncol. 2006 Jan;7(1):37-49. doi: 10.1007/s11864-006-0030-9. Curr Treat Options Oncol. 2006. PMID: 16343367 Review.

5

Current status of adjuvant chemotherapy for stage IB non-small-cell lung cancer: implications for the New Intergroup Trial.

Wakelee HA, Schiller JH, Gandara DR. Wakelee HA, et al. Clin Lung Cancer. 2006 Jul;8(1):18-21. doi: 10.3816/CLC.2006.n.028. Clin Lung Cancer. 2006. PMID: 16870041 Review.

6

Survival differences by sex for patients with advanced non-small cell lung cancer on Eastern Cooperative Oncology Group trial 1594.

Wakelee HA, Wang W, Schiller JH, Langer CJ, Sandler AB, Belani CP, Johnson DH; Eastern Cooperative Oncology Group. Wakelee HA, et al. J Thorac Oncol. 2006 Jun;1(5):441-6. J Thorac Oncol. 2006. PMID: 17409897 Free article. Clinical Trial.

7

Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors.

Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. Le QT, et al. J Thorac Oncol. 2006 Oct;1(8):802-9. J Thorac Oncol. 2006. PMID: 17409963 Free article. Clinical Trial.

8

Metabolic tumor burden predicts for disease progression and death in lung cancer.

Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW Jr. Lee P, et al. Among authors: wakelee ha. Int J Radiat Oncol Biol Phys. 2007 Oct 1;69(2):328-33. doi: 10.1016/j.ijrobp.2007.04.036. Int J Radiat Oncol Biol Phys. 2007. PMID: 17869659

9

Complications of ablative therapies in lung cancer.

Padda S, Kothary N, Donington J, Cannon W, Loo BW Jr, Kee S, Wakelee H. Padda S, et al. Clin Lung Cancer. 2008 Mar;9(2):122-6. doi: 10.3816/CLC.2008.n.019. Clin Lung Cancer. 2008. PMID: 18501100

10

Antibodies to vascular endothelial growth factor in non-small cell lung cancer.

Wakelee H. Wakelee H. J Thorac Oncol. 2008 Jun;3(6 Suppl 2):S113-8. doi: 10.1097/JTO.0b013e318174e993. J Thorac Oncol. 2008. PMID: 18520292 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

351 results

Search Page

Filters